NasdaqHealth CareHealth Care ServicesS&P SmallCap 600
$76.00
-2.01 (-2.58%)
Close of Nov 06, 2026 · end-of-day data
RDNT 8-K filings in 2025
Every material Form 8-K RadNet filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
RadNet reported third-quarter 2025 revenue of $522.9 million, up 13.4%, and Adjusted EBITDA of $84.9 million, up 15.2%. Net income attributable to RadNet stockholders was $5.4 million, or $0.07 per diluted share, compared with $3.2 million, or $0.04, a year earlier. The company raised its full-year 2025 revenue and Adjusted EBITDA guidance for the Imaging Center segment and its revenue guidance for Digital Health, which is a positive signal for shareholders.
Q3 2025 revenue was $522.9 million, up from $461.1 million; Adjusted EBITDA was $84.9 million, up 15.2%.
Q3 2025 net income attributable to RadNet was $5.4 million, or $0.07 per diluted share, versus $3.2 million, or $0.04, in Q3 2024.
Imaging Center 2025 revenue guidance was raised to $1,900 - $1,930 million and Adjusted EBITDA guidance to $276 - $284 million.
For the first nine months of 2025, the company reported a net loss of $18.1 million, or $(0.24) per share; cash was $804.7 million at September 30, 2025.
RadNet reported second-quarter 2025 revenue of $498.2 million, up 8.4% from a year earlier, and net income attributable to RadNet common stockholders of $14.5 million, or $0.19 per diluted share, compared with a net loss of $3.0 million in the second quarter of 2024. The company raised its full-year 2025 Imaging Center revenue and Adjusted EBITDA guidance ranges, which matters to shareholders because it sets a higher expected earnings base for the year.
Q2 2025 Total Company Revenue was $498.2 million, up from $459.7 million; Adjusted EBITDA was $81.2 million, up 12.3%.
GAAP net income attributable to RadNet common stockholders was $14.5 million ($0.19 per diluted share) versus a net loss of $3.0 million in Q2 2024.
Imaging Center 2025 Total Net Revenue guidance was raised to $1,850 - $1,900 million and Adjusted EBITDA guidance to $271 - $279 million.
For the first six months of 2025, the company reported a net loss attributable to RadNet common stockholders of $23.5 million.
RadNet, Inc. and its subsidiary Radnet Management, Inc. entered into an amendment to their credit agreement with Barclays Bank PLC as lender and administrative agent, adding a $100.0 million incremental term loan that matures April 18, 2031. The company plans to use the proceeds for future acquisitions and general corporate purposes, and stockholders also approved the auditor and executive pay proposals at the June 10, 2025 annual meeting.
$100.0 million 2025 Incremental Term Loan from Barclays Bank PLC, maturing April 18, 2031, alongside a $868.4 million balance of the existing term loan
Proceeds to fund future acquisitions and general corporate purposes
Quarterly principal payments rise to approximately $2.4 million from approximately $2.2 million
At the June 10, 2025 annual meeting, Ernst & Young LLP was ratified with 67,788,289 votes for, and the non-binding executive pay proposal passed with 50,822,611 votes for and 10,417,523 against
RadNet reported first-quarter 2025 revenue of $471.4 million, up 9.2%, but Adjusted EBITDA fell 20.6% to $46.4 million and the company posted a net loss attributable to RadNet of $37.9 million, compared with a $2.8 million loss a year earlier. The company raised its full-year 2025 revenue and Adjusted EBITDA guidance ranges, citing the Southern California wildfires and severe winter weather that it said reduced first-quarter revenue by about $22 million.
Total Company revenue rose to $471.4 million from $431.7 million; Adjusted EBITDA fell to $46.4 million from $58.5 million.
Net loss per share was $(0.51) versus $(0.04) a year earlier; adjusted diluted loss per share was $(0.35) versus adjusted earnings of $0.07.
Imaging Center revenue guidance was raised to $1,835 million to $1,885 million from $1,825 million to $1,875 million; Adjusted EBITDA guidance was raised to $268 million to $276 million from $265 million to $273 million.
RadNet signed a definitive agreement on April 15, 2025 to acquire iCAD, Inc., subject to customary closing conditions.
RadNet reported fourth quarter 2024 total revenue of $477.1 million, up 13.5%, and Adjusted EBITDA of $75.0 million, up 14.0%, with GAAP net income attributable to RadNet stockholders of $5.3 million compared with a net loss of $1.9 million a year earlier. For full-year 2024, GAAP net income attributable to RadNet was $2.8 million, slightly below $3.0 million in 2023, and the company issued 2025 guidance that factors in an estimated $22 million revenue and $15 million Adjusted EBITDA hit from winter weather and Southern California fires.
Q4 2024 revenue $477.1 million, up $56.7 million (13.5%) from Q4 2023; Adjusted EBITDA $75.0 million, up 14.0%
Q4 2024 GAAP net income attributable to RadNet $5.3 million, or $0.07 per diluted share, versus a net loss of $1.9 million a year earlier
Full-year 2024 GAAP net income attributable to RadNet $2.8 million versus $3.0 million in 2023
2025 guidance: Imaging Center revenue $1,825-$1,875 million; Digital Health revenue $80-$90 million
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every RadNet filing is on SEC EDGAR ↗. 8-K briefs of other companies →